Abstract
Background The symptoms of severe COVID-19 are complex and wide-ranging even in intensive care unit (ICU) patients, who may successfully discontinue respiratory support in a short period or conversely require prolonged respiratory support. Damage in the lungs of COVID-19 patients is characterized pathologically as diffuse alveolar damage, the degree of which correlates with the severity of the disease. We hypothesized that the ventilatory ratio (VR), a surrogate parameter for the dead space fraction, might stratify the severity of COVID-19 and predict the successful discontinuation of respiratory support.
Methods Forty COVID-19 patients in our ICU were enrolled in this study. Respiratory variables were collected from 2 hours (day 0) after the initiation of respiratory support. We monitored the longitudinal values of VR and other respiratory parameters for 28 days. Patients successfully discontinued from respiratory support by day 28 of ICU stay were defined as the successfully discontinued group, while those who died or failed to discontinue were defined as the failed to discontinue group. VR and other respiratory parameters were compared between these groups.
Results Except for advanced age, prolonged ventilation period, and higher mortality in the failed to discontinue group, there were no significant differences between the groups in terms of any other background or respiratory parameter at 2 hours (day 0) after initiation of respiratory support. Longitudinal VR monitoring revealed significantly higher VR values in the failed to discontinue group than the successfully discontinued group on day 4 of respiratory support. Upon predicting the failure to discontinue respiratory support, the area under the receiver operating characteristic curve of VR values on day 4 of respiratory support was 0.748. A threshold of 1.56 achieved the highest predictive performance with a sensitivity of 0.667 and a specificity of 0.762. This threshold enabled the prediction of the successfully discontinued outcome at 0.810 of the negative predictive value.
Conclusions Elevated VR values on day 4 of respiratory support were predictive of successful discontinuation of respiratory support in patients with severe COVID-19. Longitudinal VR values after initiation of respiratory support can be used as a practical index to stratify severe COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Japan Agency for Medical Research and Development (AMED) under Grant number JP20wm0125003 (Yasutoshi Kido), JP20he1122001 (Yasutoshi Kido), JP20nk0101627 (Yasutoshi Kido), and JP20jk0110021 (Yu Nakagama). This work was also supported by JSPS KAKENHI Grans Number JP21441824 (Natsuko Kaku). We also receive the COVID-19 Private Fund (to the Shinya Yamanaka laboratory, CiRA, Kyoto University). We received support from Osaka City University's "Special Reserves" fund for COVID-19.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted under the approval of the Institutional Review Board of Osaka City University (#2020-003) and the Clinical Research Ethics Committee of the Osaka Municipal Hospital Organization (#2005020), Osaka, Japan.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
kaku.natsuko{at}med.osaka-cu.ac.jp
nakagama.yu{at}med.osaka-cu.ac.jp
shirano{at}wonder.ocn.ne.jp
sallyshinomiya{at}gmail.com
kazuhiro.shimazu.0211{at}gmail.com
ymzk_ktak{at}yahoo.co.jp
yoppymae{at}yahoo.co.jp
ryo10071007mrt{at}yahoo.co.jp
yuko.nitahara74{at}gmail.com
hyamamoto{at}med.osaka-cu.ac.jp
mizobata{at}med.osaka-cu.ac.jp
kido.yasutoshi{at}med.osaka-cu.ac.jp
Data Availability
The datasets used and analyzed during the current study are available in Microsoft Excel files titled 'Supplement Table 1-4'.
List of abbreviations
- ACE2
- angiotensin-converting enzyme 2
- ARDS
- acute respiratory distress syndrome
- AUC
- area under ROC curve
- BMI
- body mass index
- COVID-19
- Coronavirus disease 2019
- DAD
- diffuse alveolar damage
- Cstat
- static lung compliance
- FiO2
- the fraction of inspired oxygen
- IBW
- ideal body weight
- ICU
- intensive care unit
- MERS-CoV
- middle east respiratory syndrome coronavirus
- MV
- minute ventilation
- PaCO2
- the partial pressure of carbon dioxide
- PaO2
- the partial pressure of oxygen
- PCR
- polymerase chain reaction
- PEEP
- positive end-expiratory pressure
- Pplat
- plateau pressure
- P/F
- PaO2 / FiO2
- ROC
- receiver operating characteristic
- SARS-CoV
- severe acute respiratory syndrome coronavirus
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
- VD/VT
- dead space fraction
- VR
- ventilatory ratio
- VT
- tidal volume